As we move towards year-end 2023, I am assembling a list of potential healthcare tickers that are worthy of consideration for a spot in one of my three healthcare portfolios (speculative, growth, ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
ShockWave’s disruptive approach within the calcified cardiovascular disease space creates a first-mover advantage offering the opportunity of robust sales growth. ShockWave Medical’s business model ...
Boston Scientific drove the cardiovascular space into a frenzy on Friday when it was announced it was rumored to acquire Shockwave Medical, according to a report from Bloomberg citing people with ...
Findings Hold Promise for Female Patients with Calcified Coronary Artery Disease Who Previously Suffered Worse Safety Outcomes than Male Patients Undergoing Atherectomy SANTA CLARA, Calif., May 19, ...
LAS VEGAS — A lithoplasty device was associated with positive 6-month outcomes in patients with symptomatic calcified femoropopliteal lesions, according to the results of the DISRUPT PAD study. The ...
Valve Performance of Self-Expanding vs. Balloon-Expandable TAVR in Patients with a Small Aortic Annulus: Five-Year Results From the OCEAN-TAVI Registry Receive the the latest news, research, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results